Hologicvs.Labcorp
HOLX vs LH · both in Diagnostics, part of the Medicine, pharma & life science value chain: Tests, imaging and assays that support clinical decision-making.
Labcorp is about 1.3× larger than Hologic by market cap; Labcorp trades at the lower P/E (24.1 vs 31.2); year to date, Labcorp leads (+10.3% vs +2.0%).
Side by side
| HOLX | LH | |
|---|---|---|
| Market cap | $17B | $22.7B |
| Price | — | $276.81 |
| Today | — | −0.3% |
| Return YTD | +2.0% | +10.3% |
| Return 1Y | −3.5% | +9.1% |
| P/E | 31.2 | 24.1 |
| P/S | 4.1 | 1.6 |
| P/B | 3.2 | 2.6 |
Data as of 2026-07-11 · updates daily after U.S. close
The two companies
HologicHOLX
American medical technology company focused on women's health — diagnostics, mammography (imaging) and surgery.
Full HOLX profile →LabcorpLH
One of the largest US clinical laboratory networks plus contract research.
Full LH profile →More comparisons in Diagnostics
See where HOLX and LH sit in the full Medicine, pharma & life science map — every segment from suppliers to end markets.Open the Life science value chain →